Form D · Biotechnology

Innovative Health Solutions, Inc.

Versailles, IN · CIK 0001720973

Offering snapshot reported Apr 14, 2020 · SEC filing

Reported sold
$9.57M
Offering amount: $17M
Investors reported
18
Form D · investor count
Minimum accepted
$1
Reported outside-investor minimum
First sale
Sep 6, 2019
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$4.78M$9.57MNov 15, 2019: $4,000,000.00Nov 15, 2019Apr 14, 2020: $9,567,000.00Apr 14, 2020

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$4,000,000 → $9,567,000
  • Reported investors11 → 18

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Apr 14, 2020Amendment$9,567,000$5,567,000vs Nov 15, 201918SEC filing
Nov 15, 2019Initial$4,000,000No comparison11SEC filing
Oct 30, 2017Initial$975,000No comparison3SEC filing

Offering details

Securities
Equity, Debt
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-353507

Source: Form D, filed Apr 14, 2020. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Christopher Robin Brown Director
Tom Carrico Director, Executive
Brian Carrico Director, Executive
Gary Peterson Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
823 S. Adams St., Suite B Box 397
Versailles, IN, 47042